| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director | Executive Chairman
1 company
James C Czirr last filed a Form 4 in February 2025, as 10% Owner at GALT. James C Czirr's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,045,541 shares of GALT. The GALT filings lean toward selling, a net 833,756 shares.
James C Czirr has 22 Form 4 filings on record from January 2015 to February 2025, all as 10% Owner at Galectin Therapeutics (GALT), 2015–2025.
The 62 reported transactions were 18 open-market sales, 12 open-market purchases, 11 other transactions and 9 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 7 sales worth about $5.2M.
The largest open-market sale was 208,140 shares of GALT at an average $7.17 on June 13, 2018, about $1.5M.
Shares as reported in the last Form 4 for each company; the most recent is from February 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2024 | GALT Galectin Therapeutics Inc | 10% Owner | Sell | 25,000 | $3.06 | $76,500.00 | -0.4% | -26.6% | -60.4% | |
| Jun 18, 2018 | GALT Galectin Therapeutics Inc | - | Sell | 151,860 | $8.61 | $1,306,806.65 | -5.4% | - | - | |
| Jun 13, 2018 | GALT Galectin Therapeutics Inc | - | Sell | 208,140 | $7.17 | $1,493,275.80 | -6.9% | - | - | |
| Jun 8, 2018 | GALT Galectin Therapeutics Inc | - | Sell | 110,000 | $5.88 | $646,800.00 | -3.5% | - | - | |
| Jun 4, 2018 | GALT Galectin Therapeutics Inc | - | Sell | 50,000 | $5.12 | $256,080.93 | -1.6% | - | - | |
| Jan 26, 2018 | GALT Galectin Therapeutics Inc | Director | Sell | 244,444 | $5.43 | $1,328,289.80 | -7.3% | - | - | |
| Apr 20, 2016 | GALT Galectin Therapeutics Inc | Director | Sell | 44,312 | $1.67 | $74,138.30 | -1.3% | - | - |